Typicality: | 0.270 |
Saliency: | 0.176 |
to develop similar cellular immunotherapies | 6 | purpose |
trial → open → the door | 9 |
negative | neutral | positive |
0.174 | 0.402 | 0.424 |
Raw frequency | 9 |
Normalized frequency | 0.176 |
Modifier score | 0.600 |
Perplexity | 123.594 |